ACC/AHA 2025 Guidelines Recognize Renal Denervation as a Valid Option for Resistant Hypertension, Backed by Global Trials and FDA-Cleared Devices
By Team VOH
The American College of Cardiology (ACC) and American Heart Association (AHA) have updated their 2025